Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:64 (12 January), doi:10.1136/bmj.39451.695775.DB
Roger Dobson
1 Abergavenny
| The first 150 words of the full text of this article appear below. |
Every extra £13 000 (
17 500; $25 700) spent each year per patient in England on cancer treatment extends an individual life by one year. And for each patient with a circulatory disease an additional £8000 is enough to increase average life expectancy by 12 months.
These are among the findings of a new health economics study (Journal of Health Economics doi: 10.1016/j.jhealeco.2007.12.002).
"These results challenge the widely held view that healthcare spending has little marginal impact on health," said Peter Smith, one of the authors, from the Centre for Health Economics at the University of York. "Our estimates suggest that, relative to received wisdom, the marginal cost of a life year saved is quite low."
The economists say that one of the most important and unresolved issues in health policy is quantifying how much is produced by additional spending on health care in terms of improved
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+